✦ LIBER ✦

ARTERIAL CARBOXYHEMOGLOBIN CONCENTRATIONS AS A PREDICTOR OF CHEMOSENSITIVITY IN ELDERLY PATIENTS WITH ADVANCED LUNG CANCER

✍ Scribed by Hiroyasu Yasuda; Mutsuo Yamaya; Katsutoshi Nakayama; Satoru Ebihara; Masanori Asada; Takahiko Sasaki; Daisuke Inoue; Motoki Yoshida; Hiroshi Kubo; Hidetada Sasaki

Book ID: 109128722
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 54
Category: Article
ISSN: 0002-8614
DOI: 10.1111/j.1532-5415.2005.00592_6.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ARTERIAL CARBOXYHEMOGLOBIN CONCENTRATION

ARTERIAL CARBOXYHEMOGLOBIN CONCENTRATIONS AS A PROGNOSTIC PREDICTOR IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER

✍ Hiroyasu Yasuda; Katsutoshi Nakayama; Satoru Ebihara; Masanori Asada; Takahiko S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A dose-finding and pharmacokinetic study

A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer

✍ Noboru Yamamoto; Tomohide Tamura; Takayasu Kurata; Nobuyuki Yamamoto; Ikuo Sekin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

Efficacy and tolerability of gefitinib i

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Activity and safety of erlotinib as seco

Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

✍ David Rossi; Donatella Dennetta; Marcello Ugolini; Vincenzo Catalano; Paolo Ales 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 129 KB

Weekly docetaxel in the treatment of eld

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Lisa H. Morrissey; Jo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 3 views

## Background: Weekly administration of docetaxel was found to reduce myelosuppression and other nonhematologic toxicities when compared with administration every 3 weeks. in the current phase ii trial, the authors evaluated the feasibility, toxicity, and efficacy of weekly docetaxel in the treatme

Assessment of functional status, symptom

Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine

✍ I. Maestu; J. Muñoz; L. Gómez-Aldaraví; G. Esquerdo; A. Yubero; M. D. Torregrosa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 177 KB